EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor

Term ID

CHEBI:131770

Synonyms

ATP phosphohydrolase (channel-conductance-controlling) inhibitor
ATP phosphohydrolase (channel-conductance-controlling) inhibitors
CFTR inhibitor
CFTR inhibitors
channel-conductance-controlling ATPase (EC 3.6.3.49) inhibitor
channel-conductance-controlling ATPase (EC 3.6.3.49) inhibitors
channel-conductance-controlling ATPase inhibitor
channel-conductance-controlling ATPase inhibitors
cystic fibrosis conductance regulator inhibitor
cystic fibrosis conductance regulator inhibitors
cystic fibrosis transmembrane conductance regulator inhibitor
cystic fibrosis transmembrane conductance regulator inhibitors
cystic-fibrosis membrane-conductance-regulating protein inhibitor
cystic-fibrosis membrane-conductance-regulating protein inhibitors
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitors
EC 3.6.3.49 inhibitor
EC 3.6.3.49 inhibitors

Definition

A EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor that interferes with the action of channel-conductance-controlling ATPase (EC 3.6.3.49, also known as cystic fibrosis conductance regulator, CFCR).

References

Wikipedia:Cystic_fibrosis_transmembrane_conductance_regulator

Ontology

ChEBI ( EBI )

Relationships

is a type of: EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor

EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor Show first 5 Terms
inverse has_role: bumetanide CFTRinh-172 glyburide

bumetanide CFTRinh-172 glyburide Show first 5 Terms

Phenotype

Phenotype resulting from EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor

Phenotype where environments contain EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor

Phenotype modified by environments containing EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor

Human Disease Model